Averitas Pharma focuses on developing innovative alternatives for managing pain and addressing unmet patient needs, with a specific emphasis on pain as a disease.

Averitas Pharma

Domain Not Resolving

Amazon

Bamboo HR

Pharmaceutical Acquired Companies

East Coast Pharmaceutical Companies

East Coast Companies that Exited (Top 10K)

New Jersey Companies With Fewer Than 1000 Employees (Top 10K)

Averitas Pharma manufactures non-opiate pain agents for specialty pharmaceuticals.

Morristown

New Jersey

United States

North America

Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain

News - Focus On, Averitas Pharma

Growth for Grünenthal with new Qutenza indication

BioPlus Specialty Pharmacy Dispensing Non-opioid Pain Medication Qutenza® (Capsaicin) 8% Patch in Exclusive Relationship

A capsaicin 8% topical system used for the management of neuropathic pain associated with postherpetic neuralgia and diabetic peripheral neuropathy of the feet.

Research focused on the Transient Receptor Potential Vanilloid 1 receptor to understand pain mechanisms and develop new pain management therapies.

Support for organizations, investigators, and individuals conducting research or educational activities related to pain management.

China

Asia

India

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 28, 2024 5:06 PM	00d5ee8d
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 28, 2024 5:06 PM	ee4b7e81
crunchbase trigger	general	Nov 22, 2024 7:44 AM	f9f3a587
crunchbase profile	general	Nov 22, 2024 3:20 PM	d9c8f6dd
li profile	general
translate crunchbase fundingrounds	general	Nov 23, 2024 1:54 AM	8317d01d
peers	general	Sep 28, 2024 5:06 PM	4fa0f005
news basic	general	Sep 28, 2024 5:06 PM	0ad496b5
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:AVERITASPHARMA

Averitas Pharma